This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics

SAVINGS DEADLINE EXPIRES:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
Delivered as Hybrid Event from 16-18 November 2022
Live In-Person Conference Delivered 16-18 NovemberAustria Center Vienna

Jacob Litke, PhD
Chief Scientific Officer & Co-Founder at Chimerna Therapeutics

Profile

Jacob Litke is Chief Scientific Officer and co-founder of Chimerna Therapeutics. Prior to working at Chimerna, he conducted postdoctoral work and received a Ph.D. from Weill Cornell Medical College in New York with Dr. Samie R. Jaffrey, where he developed protein-binding aptamers and an expression system of circular RNAs for mammalian cells.



Agenda Sessions

  • Circular RNA Aptamers as Therapeutics for Targeting Intracellular Proteins

    16:00